CMNDClearmind Medicine Inc.

Nasdaq clearmindmedicine.com


$ 1.30 $ 0.01 (0.75 %)    

Tuesday, 17-Sep-2024 15:51:59 EDT
QQQ $ 473.83 $ 0.25 (0.05 %)
DIA $ 417.12 $ -0.12 (-0.03 %)
SPY $ 563.14 $ 0.23 (0.04 %)
TLT $ 100.82 $ -0.49 (-0.48 %)
GLD $ 237.35 $ -1.32 (-0.55 %)
$ 1.34
$ 1.29 x 300
-- x --
-- - --
$ 0.92 - $ 10.35
57,389
na
813,832
$ -0.35
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 clearmind-medicine-files-international-patent-for-ibogaine-combination-therapy

Clearmind Medicine filed an international patent for a treatment that aims to enhance addiction treatment safety and efficacy.

 clearmind-medicine-and-yissum-file-international-patent-application-for-novel-psychedelic-compounds-targeting-ptsd-treatment-addressing-critical-unmet-needs

- Reuters 

 could-psychedelics-end-binge-drinking-a-breakthrough-patent-says-yes

Clearmind Medicine secures a U.S. patent for its MEAI-based binge behavior treatment, marking a significant advancement in addr...

 clearmind-medicine-yissum-expand-collaboration-with-submission-of-international-patent-application-for-generation-30-psychedelic-compounds-to-treat-mental-disorders

Clearmind Medicine Inc. (NASDAQ:CMND), (FSE: CWY0) ("Clearmind" or the "company"), a biotech company focused on...

Core News & Articles

SciSparc has been collaborating with Clearmind Medicine to create effective treatments for obesity and metabolic syndrome by co...

 clearmind-medicine-inks-pact-to-source-manufacturers-and-distributors-for-its-alcohol-substitute-beverage-product

This partnership aims to source global manufacturers and distributors for Clearmind's groundbreaking MEAI-based alcohol sub...

 clearmind-medicine-granted-patent-approval-in-hong-kong-for-its-binge-behaviors-treatment

- Reuters 

 why-psychedelic-pharma-clearmind-medicine-stock-is-moving-higher

Clearmind Medicine shares are trading higher Friday after the company announced advancement in its proprietary MEAI-based binge...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION